Teva Pharmaceutical Industries
TEVA
#1455
Rank
$9.79 B
Marketcap
$8.61
Share price
-2.93%
Change (1 day)
1.41%
Change (1 year)

P/E ratio for Teva Pharmaceutical Industries (TEVA)

P/E ratio as of November 2022 (TTM): -7.42

According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -7.42241. At the end of 2021 the company had a P/E ratio of 21.1.

P/E ratio history for Teva Pharmaceutical Industries from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202121.1
2019-10.760.27%
2018-6.65470.31%
2017-1.17-100.23%
20165181351.64%
201535.7122.07%
201416.1-39.88%
201326.7

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
8.96-220.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
9.34-225.77%๐Ÿ‡บ๐Ÿ‡ธ USA
13.8-286.08%๐Ÿ‡ซ๐Ÿ‡ท France
18.0-342.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-158 2,023.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.27-157.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
23.0-409.39%๐Ÿ‡ฎ๐Ÿ‡ณ India

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.